Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
94
mi
from 91732
La Jolla, CA
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
USCD Medical Center
94
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
103
mi
from 91732
San Diego, CA
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
1719
mi
from 91732
Maywood, IL
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
1719
mi
from 91732
Maywood, IL
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
2203
mi
from 91732
Durham, NC
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
2035
mi
from 91732
Cleveland, OH
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
UT Southwestern
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated:  12/31/1969
572
mi
from 91732
Salt Lake City, UT
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
25
mi
from 91732
Los Angeles, CA
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
UCLA
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
1911
mi
from 91732
Smyrna, GA
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
Atlanta Interventional Institute
1911
mi
from 91732
Smyrna, GA
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
1524
mi
from 91732
Rochester, MN
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
2203
mi
from 91732
Durham, NC
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
1222
mi
from 91732
Plano, TX
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
Willowbend Health and Wellness
1222
mi
from 91732
Plano, TX
Click here to add this to my saved trials
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated:  12/31/1969
2205
mi
from 91732
Charlottesville, VA
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
2205
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension
Taekwondo Training Reduces Blood Catecholamine Levels and Arterial Stiffness in Postmenopausal Women With Stage-2 Hypertension
Status: Enrolling
Updated:  12/31/1969
1297
mi
from 91732
Omaha, NE
Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension
Taekwondo Training Reduces Blood Catecholamine Levels and Arterial Stiffness in Postmenopausal Women With Stage-2 Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Nebraska Omaha
1297
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1786
mi
from 91732
Homewood, AL
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1786
mi
from 91732
Homewood, AL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1757
mi
from 91732
Mobile, AL
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1757
mi
from 91732
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
427
mi
from 91732
Tucson, AZ
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
36
mi
from 91732
Laguna Hills, CA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
36
mi
from 91732
Laguna Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
19
mi
from 91732
Los Alamitos, CA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
19
mi
from 91732
Los Alamitos, CA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2114
mi
from 91732
New Port Richey, FL
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2114
mi
from 91732
New Port Richey, FL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
941
mi
from 91732
Coeur D'Alene, ID
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
941
mi
from 91732
Coeur D'Alene, ID
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1606
mi
from 91732
Springfield, IL
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1606
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1814
mi
from 91732
Jeffersonville, IN
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1814
mi
from 91732
Jeffersonville, IN
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1415
mi
from 91732
West Des Moines, IA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1415
mi
from 91732
West Des Moines, IA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1401
mi
from 91732
Shreveport, LA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1401
mi
from 91732
Shreveport, LA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1962
mi
from 91732
Royal Oak, MI
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1962
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
649
mi
from 91732
Albuquerque, NM
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2448
mi
from 91732
Lake Success, NY
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2448
mi
from 91732
Lake Success, NY
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2102
mi
from 91732
Charlotte, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2214
mi
from 91732
Raleigh, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2275
mi
from 91732
Wilmington, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2275
mi
from 91732
Wilmington, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2032
mi
from 91732
Cleveland, OH
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1164
mi
from 91732
Oklahoma City, OK
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2375
mi
from 91732
Philadelphia, PA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
2140
mi
from 91732
Brampton,
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Research Site
2140
mi
from 91732
Brampton,
Click here to add this to my saved trials
The Sleep in Pregnancy Study
Sleep Disordered Breathing Accounts for Abnormal Glycemic Profiles in Pregnant Women: The Sleep in Pregnancy (SiP) Study
Status: Enrolling
Updated:  12/31/1969
825
mi
from 91732
Aurora, CO
The Sleep in Pregnancy Study
Sleep Disordered Breathing Accounts for Abnormal Glycemic Profiles in Pregnant Women: The Sleep in Pregnancy (SiP) Study
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
Predicting and Monitoring Motor Development of Children Requiring Surgery as Neonates for Complex Congenital Heart Disease
Status: Enrolling
Updated:  12/31/1969
1722
mi
from 91732
Oak Lawn, IL
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
Predicting and Monitoring Motor Development of Children Requiring Surgery as Neonates for Complex Congenital Heart Disease
Status: Enrolling
Updated: 12/31/1969
Advocate Children's Hospital
1722
mi
from 91732
Oak Lawn, IL
Click here to add this to my saved trials
MyHealtheVet to Enable Shared Decision Making Regarding Menopausal in Postmenopausal Women Veterans (MEANS)
MyHealtheVet to Enable Shared Decision Making Regarding Menopausal and Associated Symptoms in Postmenopausal Women Veterans
Status: Enrolling
Updated:  12/31/1969
2319
mi
from 91732
Miami, FL
MyHealtheVet to Enable Shared Decision Making Regarding Menopausal in Postmenopausal Women Veterans (MEANS)
MyHealtheVet to Enable Shared Decision Making Regarding Menopausal and Associated Symptoms in Postmenopausal Women Veterans
Status: Enrolling
Updated: 12/31/1969
Miami Veterans Affairs Healthcare System
2319
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles
Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles
Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
38
mi
from 91732
Canyon Country, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clearview Medical Research, LLC
38
mi
from 91732
Canyon Country, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
103
mi
from 91732
San Diego, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
23
mi
from 91732
Torrance, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Harbor UCLA Medical Center
23
mi
from 91732
Torrance, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
2486
mi
from 91732
New Haven, CT
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
2455
mi
from 91732
Stamford, CT
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
The Stamford Hospital
2455
mi
from 91732
Stamford, CT
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
2280
mi
from 91732
Washington,
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Office of Dr. James A. Simon, MD
2280
mi
from 91732
Washington,
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
2320
mi
from 91732
Aventura, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Ideal Clinical Research
2320
mi
from 91732
Aventura, FL
Click here to add this to my saved trials